Methods of treating subjects having diabetes with chronic kidney disease
Abstract:
The present disclosure is directed to a method of treating prediabetes or type 1 or type 2 diabetes mellitus comprising administering to a subject in need thereof an effective amount of imeglimin, wherein the subject has chronic kidney disease.
Information query
Patent Agency Ranking
0/0